Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Sculptra Aesthetic Post-Approval Study

ClinicalTrials.gov ID: NCT02425943

Public ClinicalTrials.gov record NCT02425943. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 2:04 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Open-Label, Multicenter Study to Evaluate the Long-Term Safety of Sculptra®Aesthetic in Immuno-Competent Subjects Stratified by Fitzpatrick Skin Type I-VI)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study is designed to assess the long-term safety of Sculptra Aesthetic in immune-competent subjects as a single regimen for correction of nasolabial fold (NLF) contour deficiencies and other facial wrinkles.

Study identification

NCT ID
NCT02425943
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Galderma R&D
Industry
Enrollment
867 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 21, 2015 (Actual)
Primary completion
May 28, 2021 (Actual)
Completion
May 28, 2021 (Actual)
Last update posted
Jul 27, 2023

2015 – 2021

United States locations

U.S. sites
18
U.S. states
9
U.S. cities
18
Facility City State ZIP Site status
Galderma Study Site Birmingham Alabama 32405 —
Galderma Study Site Encino California 91436 —
Galderma Study Site Hermosa Beach California 90254 —
Galderma Study Site San Diego California 92121 —
Galderma Study Site Solana Beach California 92075 —
Galderma Study Site Aventura Florida 33180 —
Galderma Study Site Boca Raton Florida 33486 —
Galderma Study Site Coral Gables Florida 33146 —
Galderma Study Site Miami Florida 33137 —
Galderma Study Site Buffalo Grove Illinois 60089 —
Galderma Study Site Hackensack New Jersey 07601 —
Galderma Study Site New York New York 10016 —
Galderma Study Site White Plains New York 10604 —
Galderma Study Site Nashville Tennessee 37215 —
Galderma Study Site Austin Texas 78746 —
Galderma Study Site Houston Texas 77056 —
Galderma Study Site Plano Texas 75093 —
Galderma Study Site Spokane Washington 99202 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02425943, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 27, 2023 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02425943 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →